GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Blackrock Health Sciences Trust (NYSE:BME) » Definitions » Beta

Blackrock Health Sciences Trust (Blackrock Health Sciences Trust) Beta : -0.19 (As of Apr. 30, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Blackrock Health Sciences Trust Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-04-30), Blackrock Health Sciences Trust's Beta is -0.19.


Blackrock Health Sciences Trust Beta Historical Data

The historical data trend for Blackrock Health Sciences Trust's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blackrock Health Sciences Trust Beta Chart

Blackrock Health Sciences Trust Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial 0.99 0.84 0.72 0.03 -0.23

Blackrock Health Sciences Trust Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.68 0.03 0.64 -0.23

Competitive Comparison of Blackrock Health Sciences Trust's Beta

For the Asset Management subindustry, Blackrock Health Sciences Trust's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blackrock Health Sciences Trust's Beta Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Blackrock Health Sciences Trust's Beta distribution charts can be found below:

* The bar in red indicates where Blackrock Health Sciences Trust's Beta falls into.



Blackrock Health Sciences Trust Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Blackrock Health Sciences Trust  (NYSE:BME) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Blackrock Health Sciences Trust Beta Related Terms

Thank you for viewing the detailed overview of Blackrock Health Sciences Trust's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Blackrock Health Sciences Trust (Blackrock Health Sciences Trust) Business Description

Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Executives
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Kyle Mcclements other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
H Erin Xie other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Catherine A. Lynch director 55 EAST 52ND STREET, NEW YORK NY 10055
Jonathan Diorio officer: Vice President 55 EAST 52ND STREET, NEW YORK NY 10055